ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Second-Line Therapy in Refractory Pancreatic Cancer. Results of a Phase II Study
Oncology Research and Treatment
◽
10.1159/000197769
◽
2009
◽
Vol 32
(3)
◽
pp. 99-102
◽
Cited By ~ 10
Author(s):
Uwe Pelzer
◽
Jens Stieler
◽
Lars Roll
◽
Andreas Hilbig
◽
Bernd Dörken
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Related Documents
Cited By
References
Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer
Oncology
◽
10.1159/000206141
◽
2009
◽
Vol 76
(4)
◽
pp. 270-274
◽
Cited By ~ 19
Author(s):
Joanna M. Brell
◽
Khalid Matin
◽
Terry Evans
◽
Robert L. Volkin
◽
Gauri J. Kiefer
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Pretreated Patients
Download Full-text
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
British Journal of Cancer
◽
10.1038/sj.bjc.6605374
◽
2009
◽
Vol 101
(10)
◽
pp. 1658-1663
◽
Cited By ~ 98
Author(s):
C Yoo
◽
J Y Hwang
◽
J-E Kim
◽
T W Kim
◽
J S Lee
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Pancreatic Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Gemcitabine Refractory
Download Full-text
Faculty of 1000 evaluation for Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718021759.793480257
◽
2013
◽
Author(s):
Ana Maria Gonzalez-Angulo
Keyword(s):
Breast Cancer
◽
Progesterone Receptor
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma
Melanoma Research
◽
10.1097/cmr.0b013e32832bbde6
◽
2009
◽
Vol 19
(3)
◽
pp. 185-192
◽
Cited By ~ 22
Author(s):
Tim Eisen
◽
José Thomas
◽
Wilson H. Miller
◽
Martin Gore
◽
Pascal Wolter
◽
...
Keyword(s):
Malignant Melanoma
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Advanced Malignant Melanoma
Download Full-text
406 POSTER Safety and efficacy of sunitinib malate (SU11248) as second-line therapy in metastatic breast cancer (MBC) patients: preliminary results from a phase II study
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(05)80704-9
◽
2005
◽
Vol 3
(2)
◽
pp. 113-114
◽
Cited By ~ 3
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Second Line
◽
Second Line Therapy
◽
Sunitinib Malate
◽
Safety And Efficacy
◽
Line Therapy
Download Full-text
Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study
Annals of Oncology
◽
10.1093/annonc/mdz339.023
◽
2019
◽
Vol 30
◽
pp. vi88
Author(s):
Yoichi Naito
◽
Toshihiko Doi
◽
Tsuyoshi Takahashi
◽
Toshihiro Kudo
◽
Narikazu Boku
◽
...
Keyword(s):
Gastrointestinal Stromal Tumor
◽
Phase Ii
◽
Phase Ii Study
◽
Stromal Tumor
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Imatinib Resistant
Download Full-text
Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study
Annals of Oncology
◽
10.1093/annonc/mdz247.168
◽
2019
◽
Vol 30
◽
pp. v324
Author(s):
V. Randrian
◽
A. Adenis
◽
J. Desrame
◽
E. Barbier
◽
F. Di Fiore
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Esophageal Squamous Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Squamous Cell
◽
Phase Ii Study
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Randomized Phase Ii
Download Full-text
A phase II study of trabectedin (ET-743) as a second line therapy in patients with persistent or recurrent endometrial carcinoma
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.5086
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 5086-5086
◽
Cited By ~ 1
Author(s):
D. S. McMeekin
◽
G. Manikas
◽
M. Crispens
◽
A. M. Orza
◽
P. Braly
◽
...
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Preliminary results of a phase II study to evaluate gefitinib (ZD1839) combined with paclitaxel (P) and carboplatin (C) as second-line therapy in patients (pts) with ovarian carcinoma (OC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.5015
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 5015-5015
◽
Cited By ~ 1
Author(s):
P. Pautier
◽
F. Joly
◽
P. Kerbrat
◽
P. Bougnoux
◽
P. Fumoleau
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Second Line Therapy
◽
Preliminary Results
◽
Line Therapy
Download Full-text
A phase II trial of perifosine as second line therapy for advanced pancreatic cancer. A study of the Princess Margaret Hospital [PMH] Phase II Consortium
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.4166
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 4166-4166
◽
Cited By ~ 4
Author(s):
D. Hedley
◽
M. J. Moore
◽
H. Hirte
◽
L. Siu
◽
M. Vincent
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Advanced Pancreatic Cancer
◽
Second Line
◽
Second Line Therapy
◽
Princess Margaret Hospital
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close